From Weight-Loss Drugs to Sleep Disorders! Lilly Plans to Acquire Centessa for Up to $7.8 Billion, Entering Narcolepsy and Wakefulness Disorder Treatment Fields
Wallstreetcn·
- Eli Lilly is set to acquire Centessa Pharmaceuticals for up to $7.8 billion, marking one of its largest acquisitions in history.
- This move fills a gap in Eli Lilly's offerings in the insomnia market, where unmet demand is high, potentially opening a multi-billion dollar market.
- Analysts suggest that the innovative orexin receptor agonist drugs may extend beyond sleep disorders to neurological and psychiatric diseases, enhancing market interest in this area.